PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis

PURPOSE: Approximately 40% of metastatic melanoma patients develop brain metastases. Our purpose was to identify genes aberrantly expressed in melanoma that might be associated with propensity for brain homing. EXPERIMENTAL DESIGN: We studied gene expression profiles in a cell line model of brain me...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Jilaveanu, Lucia B., Parisi, Fabio, Barr, Meaghan L., Zito, Christopher R., Cruz-Munoz, William, Kerbel, Robert S., Rimm, David L., Bosenberg, Marcus W., Halaban, Ruth, Kluger, Yuval, Kluger, Harriet M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4397107/
https://ncbi.nlm.nih.gov/pubmed/25316811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0861
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires